On the recordApril 24, 2012
But at the same time, our government must recognize the adverse consequences of requiring businesses to call a substance a human carcinogen without definitive evidence.
Source
congress.govBut at the same time, our government must recognize the adverse consequences of requiring businesses to call a substance a human carcinogen without definitive evidence.
Broun emphasizes the need for evidence before labeling substances as carcinogens to avoid burdening small businesses.
Share
More from Paul Broun
If we know who those people are, I think it is an outright security threat not to revoke their passports.
This is likely my last time chairing this Subcommittee on Oversight for a hearing, and I would like to thank my friends on both sides of the aisle.
The Administration didn't supply us proper witnesses to answer scientific question.
As a medical doctor, I believe that ObamaCare is the wrong prescription for what ails our nation's healthcare system.